A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA). (2022)

First Author: Stewart G
Attributed to:  Defining stroma function in the developing tumour microenvironment funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.88467

Publication URI: https://www.repository.cam.ac.uk/handle/1810/341040

Type: Journal Article/Review